With the help of your physician, search for available trials and provide relevant medical information that will help determine what options may be available to you. We do so by gathering your data securely on our GDPR-compliant, ISO 27001-certified platform.
Alongside your physician, review your options and decide what is right for you and your unique situation. If you choose to pursue an available clinical trial, we can help you take steps to get referred. If that is not possible, we can potentially help you and your physician with expanded access requests.
Whenever possible, a patient navigator is assigned to you, and helps you with guiding you through your next steps. They act as a single point of contact for patients and their families to discover and potentially access clinical trials and expanded access programs.
When the standard of care no longer meets your medical needs, navigating the path forward can be overwhelming. We recognize the complexity of understanding your options at this critical point — it’s like searching for a needle in a haystack. Our mission is to ease this journey, and we’re committed to empowering patients, their families, and physicians to know their options.
We are here to support you with finding relevant information, and an overview of clinical trials and other options. Should you and your physician choose to explore a particular option, our committed patient navigator team stands ready to help you in mapping out the journey to access it.
All our services for patients and loved ones are free of charge.
Angela Nardi, who has faced a rare cancer diagnosis, a liver transplant, and two additional cancer diagnoses, shares her story to help other patients facing similar challenges.
For Rare Disease Week, Terri Ellsworth shares her journey to becoming a patient advocate after her son was diagnosed with Duchenne muscular dystrophy.
brainstrust is an organisation dedicated to supporting patients and caregivers affected by brain tumours. myTomorrows is proud to support brainstrust’s mission and be working alongside the charity.
With over [X] years of experience in healthcare navigation, [Navigator's Name] has successfully guided numerous patients to the care and treatment they deserve. [He/She] understands the intricacies of the healthcare system and clinical trials, ensuring you have all the information you need to make informed decisions.
Discover the reliability of patient advocacy groups. Our partners are your advocates, committed to your well-being. Lean on their expertise and find hope in their support.
Curious to learn more? Explore our patient resources for in-depth insights into your treatment journey. We have FAQs, guides, and informative videos to guide you every step of the way.
We’ve combined some of our most asked questions to help you get started. You’ll find more on our FAQs page, however, please get in touch if you’d like to speak with us.
We empower patients and their physicians by offering a comprehensive overview on available options, whether it’s participating in a clinical trial or considering an expanded access program.
Patients receive equal support – with a global reach, we provide referrals to trial sites and can support physicians with the expanded access application processes worldwide. To guide patients through this intricate process, our patient navigators act as a single point of contact throughout their entire journey. Learn more about how we help patients.
Our services of providing information about clinical trials and expanded access programs and supporting physicians with the expanded access application process worldwide are always free of charge for patients and healthcare professionals.
No, myTomorrows cannot provide any medical advice or medical services to patients. We kindly recommend that you discuss with your treating physician regarding any concerns or medical guidance in considering and selecting a clinical trial or expanded access program option. Treating physicians remain in charge of their patient’s treatment plan and providing any answers on specific medical questions. Our team can only support in providing information about clinical trials and expanded access programs that may be available to patients.
Clinical trials are research studies that evaluate drugs in development. When a new treatment/drug is being researched and developed, it must be tested extensively to evaluate the safety and effectiveness of the treatment on patients’ health. Clinical trials are an essential part of developing new drugs to treat patients. Watch our video to learn more
An expanded access program is carried out at discretion of physicians for patients with an unmet medical need. It usually has broader inclusion criteria. The eligibility criteria of expanded access programs usually allow for a broader group of patients. This means that a patient who is not eligible for a clinical trial might be able to access an investigational drug via an expanded access program.
Some patients who are not eligible to participate in a clinical trial may be able to access investigational drugs outside of a clinical trial through an expanded access program.
In general, patients should meet the following criteria for an expanded access program:
In addition, each expanded access program will have its own specific criteria for patients. For most patients, the only way to access investigational therapies is to participate in a clinical trial. For a patient to enter an expanded access program, the pharmaceutical company must be willing to provide the drug through an expanded access program. myTomorrows can help with requesting this from the pharmaceutical company.
Their treating physician should discuss this with their patient and decide whether requesting the investigational drug is in their patient’s best interest. Physicians then prescribe the drug and oversee their treatment.
Each clinical trial has specific criteria to determine who can participate. These are called clinical trial eligibility criteria; they help ensure that patients who are participating in a trial are alike.
For example, they may need to have the same type and stage of disease. This helps ensure the trial’s outcomes are the result of the investigational new drug being evaluated. Clinical trial eligibility criteria are also important for the safety of the patient.
myTomorrows does not determine the eligibility of patients but helps with pre-screening them before referring them to a clinical trial. This is only done on broad criteria that are either publicly available or agreed upon with the site (age, location or gender, for instance).
Our Patient Navigators are an essential point of contact for patients to understand and find clinical trials and if available, expanded access programs.
They are a familiar contact for patients throughout their journey of choice; while they cannot give medical advice, Patient Navigators are trained to explain complex medical concepts to patients. We offer dependable, multilingual support to patients covering U.S. and European time zones.
Learn more about our services to patients here.
We treat all patient data highly confidentially and none is processed without your explicit consent. Our strict data policy restricts access to data to only qualified employees with direct operational responsibility for helping patients, and our platform and all our digital solutions are fully GDPR-compliant and ISO-27001 certified. More information is available in our privacy and cookie statements.
Do you have a question around data privacy, data processing, or data protection? Please reach out to firstname.lastname@example.org
Patients usually do not have to pay for the majority of clinical trial costs. Drug manufacturers typically make the treatment in a clinical trial available free of charge. However, there may be other costs associated with participating in a clinical trial, such as additional medical appointments or travel expenses. Review any possible costs with the clinical trial staff and with your insurance provider before enrolling in a clinical trial.
myTomorrows has a regulatory responsibility to monitor the safety of drugs prescribed through its programs. To report an adverse event or adverse drug reaction, please send an email to email@example.com.
If you lose your login and/or password, please go to the login page and click ‘forgot your password?’. An email with a link will be sent to your email address. If you still incur difficulties, please contact us via firstname.lastname@example.org.